Marksans Pharma Ltd.

Unifi Capital sold a 1.6% stake in Marksans Pharma for nearly Rs 168 crore through an open market transaction. The shares were sold at an average price of Rs 231.50 apiece.

OrbiMed divested a 2.27% stake in Marksans Pharma for Rs 257 crore through an open market transaction. The sale reduced OrbiMed's holding to 8.61%.

Indian pharma stocks plunged on Wednesday following reports that the US will soon announce tariffs on pharmaceutical imports. Blue Jet Healthcare, Marksans Pharma, Wockhardt, Glenmark...

Pharmaceutical stocks tumbled up to 10% after reports of Trump imposing tariffs on imports. Aurobindo, Laurus, Ipca, Lupin, Biocon, and Cipla were among the hardest hit.

Marksans Pharma receives USFDA approval for its generic version of Loratadine tablets, a treatment for allergic rhinitis. The approval marks a significant milestone for the company.

Adani Group and Embraer plan to announce a final assembly line for commercial aircraft in India. Boost for Make in India.

ISIR survey indicates a potential slowdown in India's luxury housing market in FY27. HNIs expect moderation in real estate outlook.

NHAI aims to reduce debt below Rs 2 lakh crore by March 2026. Debt reduced by 32% since 2023, with proactive debt management saving Rs 3,500 crore.

India and EU to announce the conclusion of FTA negotiations on January 27, boosting economic ties amid global trade disruptions.

Govt extends BIS certification deadline for aluminium cans used in beverage industry. Relief for alcoholic & non-alcoholic beverage makers.

Adani Group and Embraer plan to announce a final assembly line for commercial aircraft in India. Boost for Make in India.

Chennai Petroleum Corporation (CPCL) reports Rs 1,001.6 crore profit for Q3 2025, driven by operational excellence and improved refining margins.

LogiMAT India 2026 to boost Indo-German logistics & investment by 15%. VDMA highlights deepening partnership & growth potential.

PM Modi urges focus on quality, zero-defect manufacturing for Indian products. Highlights start-up ecosystem & Viksit Bharat.

ISIR survey indicates a potential slowdown in India's luxury housing market in FY27. HNIs expect moderation in real estate outlook.